FIELD: chemistry.
SUBSTANCE: present invention refers to the new benzotropolone derivatives of general structural formula (A) as well to their pharmaceutically acceptable salts which are able to inhibit the replication of HIV-virus, to pharmaceutical composition thereof and to the method of inhibition of HIV-virus replication. formula (A) where R1 is hydrogen; R2 is OC1-6alkyl; each of R3, R4, R5 independently is hydrogen; G is selected from the group consisting of the structures I, II; R6 is hydrogen; R7 is (CH2)bCOOR9 where b takes up the integer values from 1 to 5; R8 is selected from C1-6alkyls substituted with one or more halogen atoms; W is O; R9 is selected from hydrogen or C1-6alkyl. The structures I, II are represented in the formula of invention.
EFFECT: claimed compounds inhibit the replication of HIV-virus.
4 cl, 6 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOTROPOLONE DERIVATIVES POSSESSING ANTI HIV-ACTIVITY, PHARMACEUTICAL COMPOSITION; METHOD OF HIV-INTEGRASE INHIBITION | 2007 |
|
RU2359954C2 |
1,2,5-OXADIAZOLE DERIVATIVES, HAVING ANTI-HIV ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITING HIV-1 INTEGRASE | 2012 |
|
RU2515413C2 |
PHARMACEUTICAL AGENT FOR TREATMENT OF HIV-INFECTION, COMPOSITION CONTAINING THEREOF AND METHODS FOR ITS USING | 2002 |
|
RU2290197C2 |
METHOD FOR TREATING THE CASES OF CENTRAL NERVOUS SYSTEM INJURIES CAUSED BY HIV INFECTION BY APPLYING VX-478 ONLY OR IN COMBINATION AZT OR ZTS | 1996 |
|
RU2203658C2 |
HEMIN-PEPTIDE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND USING AS ANTI-VIRAL AND VIRULICIDE AGENT | 2004 |
|
RU2296131C2 |
DERIVATIVES OF HEMIN AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD FOR PREPARING, APPLICATION AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2238950C2 |
HEXAHYDROFURO[2,3-B]FURAN-3-YL-N-{3-[(1,3-BENZODIOXOL-5- YL- SULFONYL)(ISOBU TYL)AMINO]-1-BENZYL-2-HYDROXYPROPYL}CARBAMATE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR INHIBITION AND METHOD FOR TREATMENT | 2000 |
|
RU2247123C2 |
LIPOPEPTIDE FOR EFFECTIVE INHIBITION OF HIV, DERIVATIVE THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2017 |
|
RU2741123C1 |
NOVEL QUINOLINE DERIVATIVE FOR USE IN TREATING AND PREVENTING VIRAL INFECTIONS | 2016 |
|
RU2723013C2 |
QUINOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING VIRAL INFECTION | 2016 |
|
RU2723016C2 |
Authors
Dates
2009-06-27—Published
2007-03-30—Filed